The Hong Kong-based subsidiary of the Taiwanese insurer has backed a PE secondaries fund.
1 min read · 04 January 2021
The Carlyle subsidiary has hit the hard-cap on ASP VII and raised $1.2bn for co-investments, with support of LPs such as the California Public Employees’ Retirement System.
2 min read · 16 December 2020
ICG underwrote nearly half the transaction on Curium Pharma, an asset described as ‘cream of the crop’ by one secondaries buyer.
2 min read · 02 December 2020
Last week, Newbury Partners sold a position to GP stakes fund RidgeLake Partners. We looked at the ownership of firms that comprise our SI 30 ranking to see who might be next.
1 min read · 09 November 2020
The alternatives manager is raising the Special Opportunities fund alongside its flagship secondaries vehicle, which is targeting $3.75bn.
1 min read · 03 November 2020
Secondaries Investor reported in November that the Carlyle Group unit was targeting $8bn for its latest secondaries programme.
2 min read · 29 October 2020
The law firm advised on more than 150 secondaries transactions in 2019 with a value of $17.5bn, according to Secondaries Investor’s annual law firm survey.
1 min read · 29 October 2020
The Taiwan-based insurance company has backed Neuberger Berman Group’s fifth fund of firms vehicle.
1 min read · 23 October 2020
China Ping An Insurance Overseas is the asset management and overseas investment arm of the world’s seventh-largest listed company.
2 min read · 19 October 2020
The Taiwan-based insurance company has backed Pomona Capital’s tenth secondaries fund.
1 min read · 06 October 2020
